TheProfitWatch

KZR - Kezar Life Sciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.99 0.18 (3.01%) --- --- -0.05 (-0.8%) 0.0 (0.0%) 0.02 (0.33%) --- 0.0 (0.0%)

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-2.27
Diluted EPS:
-2.27
Basic P/E:
-2.7181
Diluted P/E:
-2.7181
RSI(14) 1m:
0.0
VWAP:
6.19
RVol:

Events

Period Kind Movement Occurred At

Related News